Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Oral Metformin in Acute Ischemic Stroke
NCT07899307Phase 3Not yet recruiting
- Sponsor
- AIIMS New Delhi
- Start
- Nov 2026
- Primary completion
- Oct 2030
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in ischemic stroke, sponsored by AIIMS New Delhi. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07899307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07899307.